UpdatesGeneral Updates
Aurobindo Pharma's subsidiary, Apitoria Pharma, concluded its US FDA inspection at Unit-VI, an API manufacturing facility.
Aurobindo Pharma LimitedAUROPHARMA · Filed with the exchange
It resulted in three procedural observations, to which the company will respond promptly.
No comments yet. Be the first.